risks of using glp 1 GLP-1 Agonists In Obesity Pulmonary Aspiration Warning for GLP-1

doi: 10.1152/ajpgi.1982.242.5.G470

Their efficacy in managing T2D and obesity is well-established, with GLP-1RAs promoting glycemic control, weight loss, and even reducing cardiovascular complications in T2D patients

Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, and Butler PC

The National Institutes of Health (NIH) defines gastroparesis as a disorder that slows or stops the movement of food from your stomach to your small intestine, even though there is no blockage in the stomach or intestines. In August 2023, the manufacturers of Ozempic and Mounjaro were sued due to their failure to warn doctors and the public of the tendency for these drugs to cause gastroparesis, or paralysis of the stomach

For years, the brand hid behind the vague "WW" initials, but for 2025, the full name is back, and it has a whole new attitude